(72 days)
Not Found
No
The description details a standard oscillometric blood pressure measurement technique and data transfer via Bluetooth, with no mention of AI or ML algorithms for data analysis or interpretation.
No
The device is intended to measure blood pressure and related parameters, not to treat a condition.
Yes
Explanation: The device measures various physiological parameters (systolic and diastolic blood pressure, pulse rate, pulse pressure, and mean arterial pressure) which are used in the diagnosis of various conditions, such as hypertension. While it doesn't make a diagnosis itself, the measurements it provides are critical inputs for diagnostic decisions made by healthcare professionals.
No
The device description clearly states it is an "Upper Arm Blood Pressure Monitor" that uses inflatable cuffs and electronic pressure sensors, indicating it is a hardware device with accompanying software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Microlife Upper Arm Blood Pressure Monitor, Model WatchBP Office (Twin200) measures blood pressure and pulse rate non-invasively by using a cuff wrapped around the upper arm. It does not analyze samples taken from the body.
- Intended Use: The intended use clearly states it measures blood pressure and pulse rate of an adult individual using a non-invasive technique.
Therefore, this device falls under the category of a non-invasive medical device used for physiological measurement, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Microlife Upper Arm Blood Pressure Monitor, Model WatchBP Office (Twin200) is a device intended to measure the systolic and diastolic blood pressure, pulse rate, pulse pressure (PP) and mean arterial pressure (MAP) of an adult individual by using a noninvasive oscillometric technique in which one (or two) inflatable cuff(s) is (are) wrapped around the single (or dual) upper arm(s).
The device can be used in connection with your personal computer (PC) running the WatchBP Office software .The memory data can be transferred to the PC by connecting the monitor with the PC via bluetooth.
Product codes
DXN
Device Description
Microlife Upper Arm Automatic Blood Pressure Monitor, Model WatchBP Office (Twin200) is designed to measure systolic and diastolic blood pressure, pulse rate, pulse pressure (PP) and mean arterial pressure (MAP) of an individual by using a non-invasive technique in which one (or two) inflatable cuff(s) is (are) wrapped around the single (or dual) upper arm(s). Our method to define systolic and diastolic pressure is similar to the auscultatory method but use two electronic pressure sensors rather than a stethoscope and mercury manometer. The sensors convert tiny alterations in cuff pressure to electrical signals, by analyzing those signals to define the systolic and diastolic blood pressure and calculating pulse rate, pulse pressure (PP) and mean arterial pressure (MAP), which is a well - known technique in the market called the "oscillometric method".
The device has >, > and > measurement modes and has inflation pressure setting function, measurement intervals setting function etc. In additional, the device can be used in connection with your personal computer (PC) running the WatchBP Office software. The memory data can be transferred to the PC by connecting the monitor with the PC via bluetooth.
The > mode is selected for blood pressure measurement of patients with arrhythmia, and, in need, to confirm if a patient is suitable for the oscillometric method using a digital blood pressure monitor. The subject device in this mode serves only as a pressure gauge. No oscillometric measurements will be taken and a mental note must be made of the systolic and diastolic values.
The > mode is selected to complete a fully-automated three consecutive measurements on both arms simultaneously, the result of these three measurements are averaged to produce the 18 visit blood pressure measurement. This mode is helpful to determine the preferred measurement arm and reveal other cardiovascular risks for a patient's first office visit.
The > mode is selected to complete a fully-automated three consecutive measurements on the preferred arm, the result of these three measurements are averaged to produce the follow-up visit blood pressure measurement.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
upper arm(s)
Indicated Patient Age Range
adult individual
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Tests Performed: Testing information demonstrating safety and effectiveness of the Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model WatchBP Office (Twin200) in the intended environment of use is supported by testing that was conducted in accordance with the FDA November 1993 Draft "Reviewer Guidance for Premarket Notification Submissions", DCRND, which outlines Electrical, Mechanical and Environmental Performance requirements. The following testing was conducted: Reliability Test (Storage test, Operating test, Vibration test, Drop test, Life test), EMC Test, IEC 60601-1 Safety Test, Bluetooth Test, and FCC Test. None of the testing demonstrated any design characteristics that violated the requirements of the Reviewer Guidance or resulted in any safety hazards. It was our conclusion that Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model WatchBP Office (Twin200) tested met all relevant requirements of the aforementioned tests.
Clinical Tests Performed: AAMI/ANSI SP-10 standard clinical testing was performed and the device met all applicable requirements of the standard.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1130 Noninvasive blood pressure measurement system.
(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).
0
OCT 2 9 2008
Exhibit#1
510(k) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
The assigned 5l0(k) number is:
Submitter's Identification: 1.
Microlife Intellectual Property GmbH, Switzerland
Espenstrasse 139 9443 Widnau / Switzerland
Date Summary Prepared: June 12, 2008
2. Name of the Device:
Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model WatchBP Office (Twin200)
3. Information for the 510(k) Cleared Device (Predicate Device):
a. Microlife Upper Arm Automatic Blood Pressure Monitor, Model WatchBP Home
(BP3MX1-1), K073198, Microlife Intellectual Property GmbH.
b. VP-2000/1000, K013434, Colin Corporation.
4. Device Description:
Microlife Upper Arm Automatic Blood Pressure Monitor, Model WatchBP Office (Twin200) is designed to measure systolic and diastolic blood pressure, pulse rate, pulse pressure (PP) and mean arterial pressure (MAP) of an individual by using a non-invasive technique in which one (or two) inflatable cuff(s) is (are) wrapped around the single (or dual) upper arm(s). Our method to define systolic and diastolic pressure is similar to the auscultatory method but use two electronic pressure sensors rather than a stethoscope and mercury manometer. The sensors convert tiny alterations in cuff pressure to electrical signals, by analyzing those signals to define the systolic and diastolic blood pressure and calculating pulse rate, pulse pressure (PP) and mean arterial pressure (MAP), which is a well - known technique in the market called the "oscillometric method".
The device has >. > and > measurement modes and has inflation pressure setting function, measurement intervals setting function etc. In additional, the device can be used in connection with your personal computer (PC) running the WatchBP Office software. The memory data can be transferred to the PC by connecting the monitor with the PC via bluetooth.
1
K082357
P2/3
The > mode is selected for blood pressure measurement of patients with arrhythmia, and, in need, to confirm if a patient is suitable for the oscillometric method using a digital blood pressure monitor. The subject device in this mode serves only as a pressure gauge. No oscillometric measurements will be taken and a mental note must be made of the systolic and diastolic values.
The > mode is selected to complete a fully-automated three consecutive measurements on both arms simultaneously, the result of these three measurements are averaged to produce the 18 visit blood pressure measurement. This mode is helpful to determine the preferred measurement arm and reveal other cardiovascular risks for a patient's first office visit.
The > mode is selected to complete a fully-automated three consecutive measurements on the preferred arm, the result of these three measurements are averaged to produce the follow-up visit blood pressure measurement.
5. Intended Use:
The Microlife Upper Arm Blood Pressure Monitor, Model WatchBP Office (Twin200) is a device intended to measure the systolic and diastolic blood pressure, pulse rate, pulse pressure (PP) and mean arterial pressure (MAP) of an adult individual by using a non-invasive oscillometric technique in which one (or two) inflatable cuff(s) is (are) wrapped around the single (or dual) upper arm(s).
The device can be used in connection with your personal computer (PC) running the WatchBP Office software .The memory data can be transferred to the PC by connecting the monitor with the PC via bluetooth.
6. Comparison to the 510(k) Cleared Device (Predicate Device):
The modified device model WatchBP Office (Twin200) and the predicate device model WatchBP Home (BP3MX1-1) use the well-known oscillometric method within the software algorithm to determine the systolic and diastolic blood pressure and pulse rate. Upper arm cuff(s) is (are) inflated automatically, deflation rate is controlled by one (or two) factory set exhaust valve(s) and the defiation pressures are transferred via tubing to one (or two) sensor(s).
The solely differences between the two models are the additional features such as measuring location (single-arm or dual-arm), PP & MAP automatically calculation function. However, the differences do not affect the accuracy and normal use of this device.
Measuring on dual-arm and PP & MAP automatically calculation function are similar with what are used in predicate device VP-2000/1000, with 510(k) cleared number K013434.
7. Discussion of Non-Clinical Tests Performed for Determination of Substantial Equivalence are as follows:
Testing information demonstrating safety and effectiveness of the Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model WatchBP Office (Twin200) in
2
the intended environment of use is supported by testing that was conducted in accordance with the FDA November 1993 Draft "Reviewer Guidance for Premarket Notification Submissions", DCRND, which outlines Electrical, Mechanical and Environmental Performance requirements.
The following testing was conducted:
- a. Reliability Test Storage test
- Reliability Test Operating test b.
- Reliability Test Vibration test ပဲ
- Reliability Test Drop test ರ
- Reliability Test Life test e.
- f. EMC Test
- IEC 60601-1 Safety Test g.
- Bluetooth Test h.
- i. FCC Test
None of the testing demonstrated any design characteristics that violated the requirements of the Reviewer Guidance or resulted in any safety hazards. It was our conclusion that Microlife Upper Arm Automatic Digital Blood Pressure Monitor. Model WatchBP Office (Twin200) tested met all relevant requirements of the aforementioned tests.
8. Discussion of Clinical Tests Performed:
AAMI/ANSI SP-10 standard clinical testing was performed and the device met all applicable requirements of the standard.
g. Software information:
The subject device's software documentation is consistent with a moderate level of concern. We provided software documentation in accordance with the FDA's November 2005 document "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices. " Moreover, our device requires the use of off-the-shelf software to operate the PC-link function and we have tested our OTC software in accordance with the FDA September 1999 document "Off-The-Shelf Software Use in Medical Device".
10. Conclusions:
We have demonstrated that there are no significant differences between the Microlife Upper Arm Automatic Digital Blood Pressure Monitor Model WatchBP Office (Twin200) and the predicate devices in terms of safety and effectiveness based on electrical, mechanical and environmental test results and the ANSI/AAMI Voluntary Standard, SP10: 2002 test results.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized eagle-like symbol with three curved lines representing its body and wings.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 2 9 2008
Microlife Intellectual Property GmbH c/o Ms. Susan D. Goldstein-Falk mdi Consultants. Inc. 55 Northern Blvd., Suite 200 Great Neck, NY 11021
Re: K082357
Trade/Device Name: Microlife Upper Arm Automatic Blood Pressure Monitor, Model WatchBP Office (Twin200) Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Measurement System Regulatory Class: Class II (two) Product Code: DXN Dated: August 15, 2008 Received: August 18, 2008
Dear Ms. Goldstein-Falk;
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with
4
Page 2 - Ms. Susan D. Goldstein-Falk
all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
er Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Exhibit B
Page _ of
510(k) Number (if known): ____________________
Device Name: Microlife Upper Arm Automatic Blood Pressure Monitor, Model WatchBP Office (Twin200)
Indications For Use:
The Microlife Upper Arm Blood Pressure Monitor, Model WatchBP Office (Twin200) is a device intended to measure the systolic and diastolic blood pressure, pulse rate, pulse pressure (PP) and mean arterial pressure (MAP) of an adult individual by using a noninvasive oscillometric technique in which one (or two) inflatable cuff(s) is (are) wrapped around the single (or dual) upper arm(s).
The device can be used in connection with your personal computer (PC) running the WatchBP Office software .The memory data can be transferred to the PC by connecting the monitor with the PC via bluetooth.
Prescription Use (Per 21 CFR 801 Subpart D)
OR
Over-The Counter Use X (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Division Sign-Off
10/28/08
ular Device
510(k) Number